Biotech and Money Ltd.

Biotech and Money Ltd.

Category: Content
Type: Blog Article

Generated 2 months ago

New blog articles detected

  • Top 4 Tips You Need To Prepare For A Biotech IPO

    Biotech companies have fared well recently in the IPO market in both the US and the UK. New legislation in the US has eased access to public markets and the AIM market in London continues to be attractive for emerging biotech companies.

  • Further additions to the lineup of presenters at the Inv€$tival Showcase

    We’re delighted to announce further additions to the lineup of presenters at the Inv€$tival Showcase in partnership with Jefferies LLC on November 18 at the Hilton Waldorf in London. Joining the showcase are a selection of international public and private life science corporates in:

Biotech and Money Ltd.

Category: Content
Type: Blog Article

Generated 2 months ago

New blog articles detected

  • Exclusive sneak peak for the 3rd annual Biotech and Money London

    You'll be blown away by what we've got planned for our next flagship congress. Full details will be coming shortly, but for now we can offer you exclusive sneak peak at our plans for the 3rd annual Biotech and Money London, taking place on February 7-8, 2017.

  • Some highlights from Biotech and Money's recent MedTech Webinar

    On September 15th we spoke exclusively to a panel of MedTech CEOs and investors in the sector for the latest in our webinar series, discussing the new funding models for MedTechs and key strategies for accessing capital during the current slowdown in earlier stage investment.

  • 9 things we learned from F2G CEO Ian Nicolson

    Ian has over 25 years of international experience in management and transactions within the life sciences sector. In addition to his role at F2G, he is currently an Operating Partner of London-based Advent Life Sciences LLP. He has worked extensively in licensing, M&A and market development in the UK, Europe and the US and holds a BSc (Hons.) from University College London and an MBA f...

  • Biotech and Money interviews Mironid

    Comprising a team with expertise in both development and commercialisation, Mironid are hoping to follow-up their recent £4.3 million series A financing with enhanced focus on R&D, exploration of potential future collaboration and the potential for series B investment in the not-too-distance future. Here are 9 things we learned when Biotech and Money spoke to Executive Chairman Dr Paul...

Biotech and Money Ltd.

Category: Content
Type: Blog Article

Generated 2 months ago

Shall we increase our level of intimacy?

40,958,160 ideas and insights to help you find what’s next.

Log in Sign up

Shall we increase our level of intimacy?

40,958,160 ideas and insights to help you find what’s next

Create Free Account

Already a user?  Log in